This inventor holds 1 USPTO granted patent. Top assignee: Vernalis Research Limited. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: David Reginald Adoms: Innovator in Purine Receptor Antagonists
Introduction
David Reginald Adoms is a notable inventor based in Wokingham, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of purine receptor antagonists. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing scientific knowledge.
Latest Patents
Adoms holds a patent for "4-Quinolinemethanol derivatives as purine receptor antagonists." This patent highlights his research and development efforts in creating compounds that may have therapeutic applications. The patent reflects his commitment to exploring new avenues in drug discovery and development.
Career Highlights
Throughout his career, David Reginald Adoms has been associated with Vernalis Research Limited, where he has contributed to various research projects. His work at the company has allowed him to collaborate with other talented scientists and push the boundaries of medicinal chemistry.
Collaborations
Adoms has worked alongside esteemed colleagues such as Roger John Gillespie and Suneel Gaur. These collaborations have fostered a productive research environment, enabling the team to explore innovative solutions in their field.
Conclusion
David Reginald Adoms is a distinguished inventor whose work in purine receptor antagonists exemplifies his dedication to scientific advancement. His contributions to Vernalis Research Limited and the patent he holds underscore his impact on the field of medicinal chemistry.